Drug Type Antibody fusion proteins |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | US | 11 Nov 2021 | |
Diabetes Mellitus, Type 2 | Preclinical | US | 11 Nov 2021 |